LifeStance Health Group, Inc

Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to info@portnoylaw.com.

Are you a current or former employee of the company?*YesNo

Purchases

+Additional Purchases

Sales

+Additional Sales

If you prefer, you may submit your transaction information or comments/questions in the box below:




There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.

We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at info@portnoylaw.com.

If you choose to take no action, you can remain an absent class member.

Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.

The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

CONTACT:
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
www.portnoylaw.com
Office: 310.692.8883
1800 Century Park East, Suite 600
Los Angeles, CA 90067
info@portnoylaw.com

On October 19, 2023, The Bear Cave released a report in which they claimed to have discovered numerous grievances related to excessive billing, fraudulent billing practices, and unfair and deceptive business conduct at LifeStance. These complaints included accusations that LifeStance was surreptitiously scheduling therapy appointments without patients’ knowledge to generate unwarranted cancellation and no-show fees. Furthermore, there were allegations that LifeStance was appending unauthorized billing codes to patient invoices, sending bills to individuals who had never utilized their services, and numerous employee testimonials highlighting concerns about billing fraud.

Following the publication of this report, LifeStance’s stock price experienced a significant decline of $0.54, equating to an 8.9% decrease, ultimately closing at $5.53 per share on October 19, 2023. This downturn adversely affected investors.